International consensus achieved on development, validation, nomenclature and quality control of multiple-loci variable-number tandem repeat analysis (MLVA) method for molecular typing of Salmonella Typhimurium: does it matter for public health?
An international consensus study on standardisation of a widely developed molecular subtyping method for Salmonella Typhimurium, multiple loci variable-number tandem repeat analysis (MLVA), was published by Nadon et al. in Eurosurveillance on 29 August 2013
Moving towards better global foodborne disease surveillance
Almost 1 in 10 people worldwide fall ill every year after eating contaminated food which commonly causes bacterial diarrhoea, resulting in 230 000 deaths each year.
Epidemiological update: Multi-country outbreak of Salmonella Enteritidis phage type 8, MLVA profile 2-9-7-3-2 and 2-9-6-3-2 infections
Since the ECDC and EFSA joint rapid outbreak assessment was published on 7 March 2017, six EU Member States (Belgium, France, Italy, Norway, Sweden and the United Kingdom) have reported 50 confirmed and 12 probable new cases associated with the multi-country outbreak of Salmonella Enteritidis phage type 8 infections (MLVA profiles 2-9-7-3-2 and 2-9-6-3-2) ongoing in the EU/EEA. In addition, twelve probable cases have been reclassified as confirmed.
Epidemiological update: multi-country outbreak of Salmonella Enteritidis with MLVA profile 2-9-7-3-2 or 2-9-6-3-2 infections
Since the previous ECDC epidemiological update was published on 30 June 2017, seven EU/EEA countries (Belgium, France, Luxembourg, the Netherlands, Norway, Sweden and the United Kingdom) have reported 96 confirmed and 34 probable new cases associated with the multi-country outbreak of Salmonella Enteritidis with MLVA profiles 2-9-7-3-2 or 2-9-6-3-2 ongoing in the EU/EEA.
Epidemiological update: Multi-country outbreak of Listeria monocytogenes PCR serogroup IVb, MLST 6
Since the publication of the rapid risk assessment on a multi-country outbreak of Listeria monocytogenes serogroup IVb, multi-locus sequence type 6 (MLST 6) on 6 December 2017, four EU Member States reported seven new confirmed outbreak cases. Two of these cases were fatal.
Understanding drug-resistant gonorrhoea: an ECDC whole genome sequencing study
Can whole genome sequencing illustrate changes in drug susceptibility of gonorrhoea to antimicrobials used for treatment and so help to define more effective treatment regimens? The first study of this kind within an international surveillance programme for sexually transmitted infections shows distribution of drug-resistant gonorrhoea strains across Europe.
Rapid progress in public health implementation of whole-genome sequencing across the EU/EEA
The EU/EEA countries are making great progress in the implementation of whole-genome sequencing (WGS) technology for outbreak investigation and surveillance. With a harmonisation of standards, this will enable exchange of WGS-derived data across the EU/EEA as prioritised in the ECDC Roadmap for molecular surveillance and improve disease control and prevention in Europe.
Call for scientific collaboration to support genomic-based surveillance of Neisseria gonorrhoeae-antimicrobial resistance at EU-level
ECDC is looking to establish a scientific collaboration with an organisation which can perform whole genome sequencing (WGS) of Neisseria gonorrhoeae, carry out related data analyses, share results of the analyses with ECDC and the participants of the European Gonococcal Antimicrobial Surveillance Programme as well as visualise the results.
OECD highlights the progress made in laboratory systems in the EU/EEA since the implementation of EULabCap
The OECD report ‘Health at a Glance: Europe 2018’ summarises the EULabCap indicator results in the chapter on public health laboratory capacity to control infectious disease threats.